0001654954-22-004478.txt : 20220401 0001654954-22-004478.hdr.sgml : 20220401 20220401170239 ACCESSION NUMBER: 0001654954-22-004478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220401 DATE AS OF CHANGE: 20220401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Michael J CENTRAL INDEX KEY: 0001035909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 22799213 MAIL ADDRESS: STREET 1: C/O EURONET WORLDWIDE, INC. STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 300 CITY: LEAWOOD STATE: KS ZIP: 66211 FORMER NAME: FORMER CONFORMED NAME: BROWN MICHAEL J DATE OF NAME CHANGE: 19970317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-03-31 false 0001645469 Monopar Therapeutics MNPR 0001035909 Brown Michael J 1000 SKOKIE BLVD STE 350 WILMETTE IL 60091 true false false Common Stock 2022-03-31 4 M false 2859 A 217153 D Common Stock 4111272.88 I See Footnote Common Stock 166667 I See Footnote Restricted Stock Units 2022-03-31 4 M false 2859 0 D Common Stock 2859 8577 D Represents shares acquired on vesting and settlement of restricted stock units. This is based upon the 4,111,272.88 shares of Monopar common stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Mr. Brown disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 166,667 shares. Mr. Brown disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto, Attorney-in-fact 2022-04-01